Boston Scientific Corporation ($BSX) Stock Forecast: Up 5.0% Today

What is Boston Scientific Corporation?

Boston Scientific (BSX) is a leading medical technology company that specializes in the development of innovative medical solutions. The company operates in the cardiovascular, MedSurg, and rhythm management segments.

Why is Boston Scientific Corporation going up?

BSX stock is up 5.0% on Oct 22, 2025 14:42

• Boston Scientific (BSX) reported strong Q3 earnings with a 19% growth in EPS, surpassing market expectations. This positive financial performance, along with raising their 2025 sales and EPS outlook, contributed to the bullish movement in the stock.
• The acquisition of Nalu Medical Inc., a maker of minimally invasive devices for chronic pain treatment, for approximately $533 million also boosted investor confidence in Boston Scientific's growth prospects.
• The company's robust cardiovascular performance, driven by innovative products like WATCHMAN FLX Pro and AGENT DCB, is expected to further enhance its earnings potential, attracting more investors to the stock.

BSX Price Chart

BSX Technical Analysis

BSX News

Boston Scientific Beats on Q3 Earnings, Raises 2025 View, Stock Up

BSX posts strong Q3 with 19% EPS growth, lifts 2025 sales and EPS outlook as shares edge higher.

https://www.zacks.com/stock/news/2773960/boston-scientific-beats-on-q3-earnings-raises-2025-view-stock-up

Boston Scientific ( BSX ) Q3 Earnings and Revenues Top Estimates

Boston Scientific (BSX) delivered earnings and revenue surprises of +5.63% and +1.94%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2773807/boston-scientific-bsx-q3-earnings-and-revenues-top-estimates

Are Medical Stocks Lagging Boston Scientific ( BSX ) This Year?

Here is how Boston Scientific (BSX) and Amarin (AMRN) have performed compared to their sector so far this year.

https://www.zacks.com/stock/news/2772278/are-medical-stocks-lagging-boston-scientific-bsx-this-year

Why Is Boston Scientific Stock Gaining Friday? - Boston Scientific ( NYSE:BSX )

Boston Scientific Corp ( NYSE:BSX ) announced on Friday that it has agreed to acquire Nalu Medical Inc., a privately held maker of minimally invasive devices for chronic pain treatment. The deal includes an upfront cash payment of about $533 million for the remaining equity Boston Scientific ...

https://www.benzinga.com/m-a/25/10/48277006/boston-scientific-to-acquire-nalu-medical-in-600-million-pain-relief-deal

Will Robust Cardiovascular Performance Fuel BSX's Q3 Earnings?

Boston Scientific's strong cardiovascular and MedSurg momentum, powered by innovations like WATCHMAN FLX Pro and AGENT DCB, could drive solid Q3 results.

https://www.zacks.com/stock/news/2769946/will-robust-cardiovascular-performance-fuel-bsxs-q3-earnings

Trending Today

Martin Marietta Materials Inc. ($MLM) Stock Forecast: Down 1.9% Today

Super Micro Computer Inc ($SMCI) Stock Forecast: Down 10.8% Today

Humana Inc. ($HUM) Stock Forecast: Down 7.3% Today

Sempra Energy ($SRE) Stock Forecast: Up 1.2% Today

Johnson Controls International plc ($JCI) Stock Forecast: Up 7.9% Today

Blink Charging Co. ($BLNK) Stock Forecast: Up 5.6% Today

Jetblue Airways Corporation ($JBLU) Stock Forecast: Up 5.4% Today

Lucid Motors Inc. ($LCID) Stock Forecast: Up 5.8% Today

Southwest Airlines Company ($LUV) Stock Forecast: Up 5.2% Today

V.F. Corporation ($VFC) Stock Forecast: Up 5.4% Today

Boston Scientific Corporation Price History

24.06.2025 - BSX Stock was down 1.9%

• BSX reported strong Q2 earnings, exceeding estimates and raising its full-year outlook.
• Despite the positive earnings, the stock saw a bearish movement, possibly due to profit-taking by investors who had already factored in the positive news.
• The market's negative reaction may stem from concerns about BSX's ability to maintain its growth momentum in the future, leading some investors to sell off their positions.
• Broader market conditions or sector-specific factors could have influenced the bearish movement in BSX, despite the favorable earnings report.

04.03.2025 - BSX Stock was down 5.4%

• BSX stock saw a -1.55% decline, ending the day at $98.50.
• The stock has been consistently decreasing, with a 3.16% drop in the current session and a 1.95% decrease over the past month.
• Despite a 44.16% rise over the last year, investors are questioning whether BSX presents a better value proposition compared to other stocks in the Medical Products sector.
• The recent bearish movement seems to stem from profit-taking following significant prior gains, as investors reevaluate the company's value and growth potential vis-à-vis competitors like Phibro Animal Health (PAHC).

02.06.2025 - BSX Stock was down 2.5%

• BSX, having outpaced market performance recently, saw a downturn in its stock value.
• Comparisons to peers such as PAHC and MDT may have contributed to investor apprehension about BSX's future trajectory.
• Intensified competition from Medtronic within the MedSurg segment potentially prompted doubts regarding BSX's market stance and growth opportunities.
• Investors appeared to revisit their perspectives on BSX's value proposition, resulting in today's bearish market activity.

10.03.2025 - BSX Stock was up 7.5%

• BSX stock surged 6.8% in a bullish movement today.
• The positive price movement could be attributed to the market's optimism about the company's future growth prospects.
• Despite a recent drop in share price and earnings estimate revisions, investors seem to be confident in BSX's long-term potential, possibly driven by successful product developments or strategic partnerships.
• The overall bullish sentiment towards BSX today may indicate that investors believe in the company's ability to deliver strong financial performance in the coming periods.

22.09.2025 - BSX Stock was up 5.0%

• Boston Scientific (BSX) reported strong Q3 earnings with a 19% growth in EPS, surpassing market expectations. This positive financial performance, along with raising their 2025 sales and EPS outlook, contributed to the bullish movement in the stock.
• The acquisition of Nalu Medical Inc., a maker of minimally invasive devices for chronic pain treatment, for approximately $533 million also boosted investor confidence in Boston Scientific's growth prospects.
• The company's robust cardiovascular performance, driven by innovative products like WATCHMAN FLX Pro and AGENT DCB, is expected to further enhance its earnings potential, attracting more investors to the stock.

02.08.2025 - BSX Stock was up 1.5%

• BSX had a strong bullish movement today, potentially driven by the company's consistent outperformance in the market over the past 5 years, with an average annual return of 20.59%.
• The comparison with other medical stocks may have highlighted BSX's strong performance, attracting investors looking for growth opportunities in the sector.
• Investors might be optimistic about BSX's future prospects, considering its track record of innovation and market leadership in the medical technology industry.

15.09.2025 - BSX Stock was up 4.3%

• BSX closed at $95.41 after a -1.92% shift in the latest trading session, showing a predominantly bullish trend.
• Comparisons with other value stocks like PAHC imply that BSX may offer better value, attracting more investors and positively impacting the market.
• The minor decline in the stock price could be linked to profit-taking following notable gains, yet the outlook for BSX remains optimistic.

06.07.2025 - BSX Stock was down 2.2%

• The bearish movement in BSX today could be attributed to investors comparing the stock with GE HealthCare Technologies (GEHC) and potentially finding more value in the latter.
• The overly optimistic views of Wall Street analysts on BSX might have raised concerns among investors about the stock's actual performance, leading to a sell-off.
• Investors may have also reacted to broader market trends or specific industry news impacting medical product companies, causing a negative sentiment towards BSX in today's trading session.

23.03.2025 - BSX Stock was up 5.5%

• BSX stock demonstrated significant bullish momentum recently.
• The company disclosed Q1 earnings and revenues that exceeded expectations, signaling robust financial results.
• Market participants seem to be responding favorably to the strong performance, displaying trust in Boston Scientific's potential for growth.
• The impressive earnings and revenue figures are likely fueling heightened investor confidence and enthusiasm for the stock, contributing to its current upward trajectory.

23.03.2025 - BSX Stock was up 5.5%

• Boston Scientific Corporation (BSX) raised its annual outlook after reporting strong sales in heart devices in Q1, beating revenue and earnings estimates.
• The company's cardiovascular sales saw significant growth, particularly in cardiology products, which contributed to the overall positive performance.
• The stock price surged as investors reacted positively to the company's robust Q1 earnings and revenue results, leading to an optimistic outlook for the future.
• Boston Scientific's solid product portfolio and financial performance in Q1 2025 have instilled confidence in investors, driving the stock price higher.

10.03.2025 - BSX Stock was down 5.3%

• Analysts view BSX as a promising investment, yet the stock saw a decline, possibly linked to investors capitalizing on profits.
• Following a notable increase in BSX's share price in the previous session, today's drop suggests a shift in market sentiment.
• The stock price of BSX declined by 1.55%, potentially due to investors seizing the opportunity to secure profits following the recent upsurge.

01.09.2025 - BSX Stock was down 3.8%

• The bearish movement in Boston Scientific's stock today could be attributed to profit-taking by investors after a prolonged period of outperformance.
• The comparison between Boston Scientific and Phibro Animal Health in terms of value might have led some investors to shift their focus, causing a temporary dip in BSX stock.
• Market sentiment or broader economic factors could also have played a role in the bearish movement of Boston Scientific's stock today.